Limerick, Ireland

Hermogenes Escala

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Carefusion 303, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hermogenes Escala. Retrieved from https://idiyas.com/inventor/hermogenes-escala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hermogenes Escala and Real-Time Infusion Monitoring.

Introduction

Hermogenes Escala is an inventor associated with Limerick, Ireland. His patent work addresses monitoring fluid volume and flow rate during an infusion process.

Latest Patents

Escala is associated with 1 patent: “Real Time Detection and Monitoring of Fluid Volume and Flow Rate.” The patent describes a method that compares an infusion device’s programmed flow rate with the rate determined from changes in the infusion container’s weight over time. If the difference meets a predetermined threshold, the device or weight sensor indicates a fault condition.

Career Highlights

Escala is associated with CareFusion 303, Inc. His patent focuses on detecting potential infusion faults by using weight measurements to assess fluid delivery.

Collaborations

The provided information lists Daniel M. Abal and James Hennessy as Escala’s coworkers. It does not specify their roles in the patent or the extent of their collaboration.

Conclusion

Hermogenes Escala’s patent describes a weight-based approach to identifying discrepancies in infusion flow, connecting his inventive work with CareFusion 303, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…